Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706481200 on December 20, 2007

J. Biol. Chem., Vol. 283, Issue 8, 4560-4567, February 22, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/8/4560    most recent
M706481200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimple, M. E.
Right arrow Articles by Casey, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimple, M. E.
Right arrow Articles by Casey, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G{alpha}z Negatively Regulates Insulin Secretion and Glucose Clearance*

Michelle E. Kimple{ddagger}, Jamie W. Joseph§, Candice L. Bailey{ddagger}, Patrick T. Fueger§, Ian A. Hendry, Christopher B. Newgard{ddagger}§||, and Patrick J. Casey{ddagger}||1

From the Departments of {ddagger}Pharmacology and Cancer Biology and ||Biochemistry and Biophysics, and §The Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina 27710 and the Division of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 0200 Australia

Relatively little is known about the in vivo functions of the {alpha} subunit of the heterotrimeric G protein Gz (G{alpha}z). Clues to one potential function recently emerged with the finding that activation of G{alpha}z inhibits glucose-stimulated insulin secretion in an insulinoma cell line (Kimple, M. E., Nixon, A. B., Kelly, P., Bailey, C. L., Young, K. H., Fields, T. A., and Casey, P. J. (2005) J. Biol. Chem. 280, 31708–31713). To extend this study in vivo, a G{alpha}z knock-out mouse model was utilized to determine whether G{alpha}z function plays a role in the inhibition of insulin secretion. No differences were discovered in the gross morphology of the pancreatic islets or in the islet DNA, protein, or insulin content between G{alpha}z-null and wild-type mice. There was also no difference between the insulin sensitivity of G{alpha}z-null mice and wild-type controls, as measured by insulin tolerance tests. G{alpha}z-null mice did, however, display increased plasma insulin concentrations and a corresponding increase in glucose clearance following intraperitoneal and oral glucose challenge as compared with wild-type controls. The increased plasma insulin observed in G{alpha}z-null mice is most likely a direct result of enhanced insulin secretion, since pancreatic islets isolated from G{alpha}z-null mice exhibited significantly higher glucose-stimulated insulin secretion than those of wild-type mice. Finally, the increased insulin secretion observed in G{alpha}z-null islets appears to be due to the relief of a tonic inhibition of adenylyl cyclase, as cAMP production was significantly increased in G{alpha}z-null islets in the absence of exogenous stimulation. These findings indicate that G{alpha}z may be a potential new target for therapeutics aimed at ameliorating β-cell dysfunction in Type 2 diabetes.


Received for publication, August 6, 2007 , and in revised form, December 10, 2007.

* This work was supported by National Institutes of Health Grants DK67799 (to M. E. K.), DK42583 (to C. B. N.), and GM55717 (to P. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Duke University Medical Center, Box 3813, Durham, NC 27710-3813. Tel.: 919-613-8613; Fax: 919-613-8642; E-mail: casey006{at}mc.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. J. Ernst, L. Aguilar-Bryan, and J. L. Noebels
Sodium Channel {beta}1 Regulatory Subunit Deficiency Reduces Pancreatic Islet Glucose-Stimulated Insulin and Glucagon Secretion
Endocrinology, March 1, 2009; 150(3): 1132 - 1139.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement